Two Ebola treatments prove effective in DRC outbreak
A study of four Ebola therapeutics demonstrated that two drugs showed significantly improved survival rates, leading to the trial being halted early.
Browsing: Ebola
One year into the DRC Ebola outbreak – is there an end in sight?
The outbreak of Ebola in the Democratic Republic of Congo has seen over 2612 cases and 1756 mortalities since it was first announced by the WHO on 1 August 2018. One year on we ask, what have the major milestones been of this outbreak? And where are we now; is there an end in sight?
Ebola outbreak declared a Public Health Emergency of International Concern
The fourth International Health Regulations Emergency Committee meeting has concluded by declaring a Public Health Emergency of International Concern, following the recent Ebola virus disease outbreak in the Democratic Republic of the Congo.
Cases of Ebola confirmed in Uganda
The Ministry of Health and WHO have reported the first case of Ebola confirmed in Uganda during the outbreak in neighbouring Democratic Republic of the Congo.
ECCMID19: Immune response to Ebola 2 years post-infection could provide clues for vaccine development
Two years after Ebola infection, survivors exhibit specific memory T cell responses against ebolavirus, according to new research presented at ECCMID.
Bombali ebolavirus discovered in bats in Kenya
A recently discovered species of the ebolavirus, the Bombali virus, has been identified in bats in Kenya, marking the first time any ebolavirus has been found in wildlife on the east coast of Africa.
Institutional trust and misinformation: the impact on Ebola control efforts
A new population-based survey has reported that low levels of public trust could have impacted the Ebola control efforts in the Democratic Republic of Congo, with a quarter of individuals not believing the virus was real and refusing vaccination.
Ebola outbreak in the Democratic Republic of Congo is second worst ever recorded
Ebola case numbers reach 426 in the current outbreak in the Democratic Republic of Congo, making this the second largest ever seen for the virus.
First-ever multi-drug Ebola trial launched in the Democratic Republic of Congo
A new trial has begun in the Democratic Republic of Congo, aiming to collect robust data on the safety and efficacy of investigational Ebola therapeutics.
Ebola nucleocapsid modeled to near-atomic resolution
A team from the Okinawa Institute of Science and Technology Graduate University has used cryo-EM to model the nucleocapsid protein of Ebola virus, potentially uncovering novel drug targets.
